Enovix Corporation $ENVX Stock Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. grew its position in Enovix Corporation (NASDAQ:ENVX) by 58.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 454,446 shares of the company’s stock after acquiring an additional 166,892 shares during the period. Oppenheimer & Co. Inc. owned 0.21% of Enovix worth $1,318,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. NewEdge Advisors LLC raised its stake in shares of Enovix by 4.7% in the first quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock worth $215,000 after acquiring an additional 1,853 shares during the last quarter. Wealthfront Advisers LLC raised its position in Enovix by 27.8% in the 1st quarter. Wealthfront Advisers LLC now owns 13,800 shares of the company’s stock worth $71,000 after purchasing an additional 3,001 shares during the last quarter. Harbor Investment Advisory LLC lifted its holdings in Enovix by 32.5% during the 2nd quarter. Harbor Investment Advisory LLC now owns 18,740 shares of the company’s stock worth $114,000 after buying an additional 4,600 shares in the last quarter. Refined Wealth Management boosted its position in Enovix by 0.7% in the 3rd quarter. Refined Wealth Management now owns 850,768 shares of the company’s stock valued at $2,467,000 after buying an additional 5,918 shares during the last quarter. Finally, Pictet Asset Management Holding SA increased its stake in shares of Enovix by 23.5% in the 1st quarter. Pictet Asset Management Holding SA now owns 33,287 shares of the company’s stock valued at $172,000 after buying an additional 6,338 shares during the period. 50.92% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ENVX shares. Craig Hallum set a $7.00 price objective on Enovix in a research note on Thursday, August 13th. Wall Street Zen downgraded shares of Enovix from a “sell” rating to a “strong sell” rating in a research report on Saturday. B. Riley Financial reduced their price objective on shares of Enovix from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Thursday, August 13th. Loop Capital raised shares of Enovix to a “strong-buy” rating in a research note on Monday, August 17th. Finally, TD Cowen raised shares of Enovix to a “hold” rating in a report on Monday, October 5th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Enovix presently has a consensus rating of “Moderate Buy” and a consensus target price of $10.77.

Enovix Stock Performance

Shares of ENVX stock opened at $3.15 on Monday. Enovix Corporation has a 12 month low of $2.20 and a 12 month high of $12.40. The company’s fifty day simple moving average is $2.95 and its 200-day simple moving average is $5.16. The firm has a market cap of $691.27 million, a PE ratio of -3.89 and a beta of 2.34. The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46.

Enovix’s stock is going to split before the market opens on Friday, November 13th. The 5-4 split was recently announced. The newly issued shares will be payable to shareholders after the market closes on Thursday, November 12th.

Enovix (NASDAQ:ENVX) last issued its earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02. The company had revenue of $9.02 million for the quarter, compared to analysts’ expectations of $8.43 million. Enovix had a negative net margin of 473.89% and a negative return on equity of 64.50%. Enovix’s quarterly revenue was up 20.8% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.13) EPS. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. Equities research analysts expect that Enovix Corporation will post -0.79 EPS for the current fiscal year.

Enovix Company Profile

Enovix Corporation is a battery technology company that develops lithium-ion batteries using a silicon-anode architecture. Its approach is designed to increase energy density while maintaining safety and cycle-life characteristics through a three-dimensional cell design and a mechanical constraint system that helps manage silicon expansion during charging.

The company’s products are intended for applications that require compact, high-performance power sources, including consumer electronics, wearable devices, Internet of Things equipment, industrial products, and defense and aerospace systems.